CClinicalTrials.gg
CompletedNCT04031443Updated Jul 15, 2020

Prescription Pattern and Awareness About Antibiotic Prophylaxis and Resistance

An observational study in Antibiotic Prescription, sponsored by Cairo University. Completed at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2020-07-15.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
378
Sex
All
01

Study summary

To assess the knowledge of Pediatric dentists regarding the prescription of antibiotics, antibiotic prophylaxis and antibiotic resistance

Read the detailed description

Antibiotics commonly are prescribed by dentists, and the uses and abuses of these drugs should be familiar to all practicing clinicians. Antibiotics are used in dentistry for two major reasons: to control oral infection, and to prevent a bacteremia precipitated by dental manipulations from causing severe systemic sequelae.

In recent years, there has been an increasing tendency to reduce the widespread use of antibiotics for prophylactic and therapeutic purposes. This is based, both on increasing scientific evidence and enhanced professional experience. The development of resistant strains of microorganisms, doubt on the efficacy of the proposed prophylactic regimens, possible toxic and adverse reactions to antibiotics and poor compliance by patients and dentists raised questions about risks and benefits.

The American Academy of Pediatric Dentistry (AAPD) has published guidelines for antibiotic use, recognizing the increasing prevalence of antibiotic-resistant microorganisms. The guidelines are intended to provide guidance for the proper and judicious use of antibiotic therapy in the treatment of oral conditions in children.

Good knowledge about the indications of antibiotics is the need of the hour in prescribing antibiotics for dental conditions. Dental practitioners should know the protocol to be applied in their patients and should apply the most recent guidelines regarding antibiotic regimen.

02

Conditions studied

  • Antibiotic Prescription

Keywords

  • prescription pattern
  • antibiotic prophylaxis
  • antibiotic resistance
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

dental practitioner who deal with children

Inclusion criteria

  • Dental practitioner

    • Deal with children

Exclusion criteria

  • Undergraduate student
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
378 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The prescription pattern of antibiotics among Pediatric dentists

    measured by Questionnaire and the measuring unit is binary yes or no

    Time frame: 1 month

Secondary outcomes

  1. Most common antibiotic prescribed, duration and dosage

    measured by Questionnaire and the measuring unit is open ended questions

    Time frame: 1 month

  2. Clinical conditions for which antibiotics were prescribed

    measured by Questionnaire and the measuring unit is Multiple choice questions

    Time frame: 1 months

  3. Awareness about antibiotic prophylaxis

    measured by Questionnaire and the measuring unit is binary yes or no

    Time frame: 1 month

  4. Awareness about antibiotic resistance

    measured by Questionnaire and the measuring unit is binary yes or no

    Time frame: 1 month

07

Study locations

1 site
  • Cairo University
    Cairo, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04031443
Lead sponsor
Cairo University
Responsible party
marwa aly fouad elchaghaby (Lecturer of Pediatric Dentistry and Dental public health, Faculty of Dentistry, Cairo University, Egypt., Cairo University) — Principal investigator
First posted
Jul 24, 2019
Start date
Nov 11, 2019
Primary completion
May 31, 2020
Completion
Jun 15, 2020
Last update
Jul 15, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion